Literature DB >> 16008658

Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.

Jillian Wells1, Steven Kossard, Michael McGrath.   

Abstract

46-year-old woman developed painful ulcers over her lower abdomen in the form of reticulate erythema after injecting interferon beta-1b subcutaneously for multiple sclerosis. Skin biopsy revealed multiple superficial thrombosed vessels with focal epidermal necrosis as well as prominent interstitial mucinosis. Treatment with low-molecular-weight heparin followed by a heparinoid resulted in slow healing of the ulcers but also allowed the subcutaneous interferon injections to be continued.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008658     DOI: 10.1111/j.1440-0960.2005.00181.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin.

Authors:  Małgorzata Sobieszczańska; Sławomir Tubek; Ilona Kura
Journal:  Hum Vaccin Immunother       Date:  2014-01-17       Impact factor: 3.452

2.  Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Authors:  Ally-Khan Somani; Alan R Swick; Kevin D Cooper; Thomas S McCormick
Journal:  Arch Dermatol       Date:  2008-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.